Skip to main
ALLO
ALLO logo

ALLO Earnings Dates & Reports

ALLO Most Recent Earnings

Report DateMay 13, 2025
Period EndingQ1 2025
Est. EPS-$0.29
Actual EPS-$0.28
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ALLO Earnings per Share (EPS) History

Signup for full access
Browse free

ALLO Latest Earnings

The value each ALLO share was expected to gain vs. the value each share gained.

ALLO reported its most recent earnings on May 13, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.28. This exceeded analysts' expectations of -$0.29 by 3.45%, marking a Beat.

For comparison, Allogene Therapeutics Inc reported EPS of -$0.38 in the same quarter last year.

The company is expected to announce its next earnings report on 08/06/2025, with analysts projecting an EPS of -$0.26.

ALLO Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2025Aug 6, 2025
-$0.26Next earnings call Aug. 6, 2025
Q1 2025May 13, 2025
-$0.29-$0.28-3.45%
DeckReportListen
Q4 2024Mar 13, 2025
-$0.34-$0.28-17.65%
Q3 2024Nov 7, 2024
-$0.33-$0.32-3.03%
Q2 2024Aug 7, 2024
-$0.35-$0.350.00%
View all

ALLO Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Allogene Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 13, 2025
Mar 13, 2025
Nov 7, 2024
Aug 7, 2024

ALLO Earnings FAQs

ALLO last reported earnings on May 13, 2025 for Q1 2025, posting an EPS of -$0.28, which Beat the estimate of -$0.29 by 3.45%.

For Q1 2025, ALLO reported an EPS of -$0.28, exceeding analysts' estimate of -$0.29 by 3.45%.

For Q1 2025, ALLO Beat expectations with an actual EPS of -$0.28 vs. an estimated EPS of -$0.29.

Following the last earnings report on May 13, 2025, ALLO's stock price moved — from — to —.

The next ALLO earnings call is scheduled for Aug. 6, 2025, where executives will discuss financial results and outlook.

Allogene Therapeutics Inc (ALLO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.